Deep Apple Therapeutics, announced a research collaboration and exclusive worldwide license agreement with Novo Nordisk to discover, develop and commercialize oral small molecule therapies...
Psilera, a biotechnology company developing groundbreaking therapies for hard-to-treat neurological disorders and Hesperos a leader in organ-on-a-chip technology, announced a strategic agreement to accelerate...
Fable Therapeutics, a discovery-stage biotechnology company developing purpose-built biologics powered by state-of-the-art structure and sequence-based protein language models, announced the appointment of David J....
Neurocrine Biosciences, announced the appointment of Lewis Choi as Chief Information Officer, effective June 9, 2025. Choi, an accomplished leader with 25 years of experience in information technology...
Nkarta, a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies to treat autoimmune disease, announced the appointment of Shawn Rose, M.D. Ph.D.,...
